<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30359235</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1471-2407</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>18</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>25</Day>                    </PubDate>                </JournalIssue>                <Title>BMC cancer</Title>                <ISOAbbreviation>BMC Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>1037</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-018-4935-z</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Combined anthracycline-trastuzumab chemotherapy has been associated with LV dysfunction. We aimed to assess early changes in left ventricular (LV) and right ventricular (RV) mechanics associated with combined anthracycline-trastuzumab treatment for breast cancer. As well as explore whether early changes in 2-dimensional (2D)-speckle tracking echocardiography (STE) could predict later chemotherapy-induced cardiotoxicity.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Sixty-six patients with breast cancer who received anthracycline-trastuzumab treatment were included (mean [±SD] age, 52 [9] years). Echocardiograms were available for analysis with 2D-STE at the following time points: pretreatment (T0), first cycle (T1), and second cycle (T2) of combined chemotherapy. All patients had a normal pretreatment LV ejection fraction (LVEF). Cardiotoxicity was defined as a decrease in LVEF of at least 10 percentage points from baseline on follow-up echocardiography.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Cardiotoxicity developed in 13 of the 66 patients (20%). The mean (±SD) LVEF at T0 was 66% (±6); at T1 60% (±7); and at T2, 54% (±6). For the 53 patients without cardiotoxicity, the LVEF was 65% (±4%) at T0, 63% (±5%) at T1, and 62% (±4) at T2. Global longitudinal strain (GLS) at T1 was the strongest indicator of subsequent cardiotoxicity (area under the curve, 0.85; cutoff value, - 14.06; sensitivity, 91%; specificity, 83%; P = .003). Compared with baseline (T0), left ventricular longitudinal strain, LV circumferential strain, circumferential peak systolic strain rate (SR), circumferential peak early diastolic SR, right ventricular longitudinal strain, and longitudinal peak systolic SR at T1 and T2 were reduced significantly in patients with cardiotoxicity (P &lt; .05).</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Anthracycline-trastuzumab treatment leads to early deterioration of LV GLS, circumferential strain, and systolic SR. Right ventricular GLS and SR were also affected. Early changes in GLS are good predictors of subsequent development of anthracycline-trastuzumab-induced cardiotoxicity.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Arciniegas Calle</LastName>                    <ForeName>Maria C</ForeName>                    <Initials>MC</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sandhu</LastName>                    <ForeName>Nicole P</ForeName>                    <Initials>NP</Initials>                    <AffiliationInfo>                        <Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xia</LastName>                    <ForeName>Hongmei</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cha</LastName>                    <ForeName>Stephen S</ForeName>                    <Initials>SS</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Biostatistics, Mayo Clinic, Scottsdale, AZ, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pellikka</LastName>                    <ForeName>Patricia A</ForeName>                    <Initials>PA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ye</LastName>                    <ForeName>Zi</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Herrmann</LastName>                    <ForeName>Joerg</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Villarraga</LastName>                    <ForeName>Hector R</ForeName>                    <Initials>HR</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. villarraga.hector@mayo.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. villarraga.hector@mayo.edu.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>25</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>BMC Cancer</MedlineTA>            <NlmUniqueID>100967800</NlmUniqueID>            <ISSNLinking>1471-2407</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Circ Cardiovasc Imaging. 2009 Sep;2(5):356-64</RefSource>                <PMID Version="1">19808623</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JACC Cardiovasc Imaging. 2017 Apr;10(4):398-407</RefSource>                <PMID Version="1">27639764</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Heart Fail. 2001 Jun;3(3):315-22</RefSource>                <PMID Version="1">11378002</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Soc Echocardiogr. 2013 Aug;26(8):846-52</RefSource>                <PMID Version="1">23727115</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Coll Cardiol. 2011 May 31;57(22):2263-70</RefSource>                <PMID Version="1">21616287</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2011 Oct 6;365(14):1273-83</RefSource>                <PMID Version="1">21991949</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Heart J Cardiovasc Imaging. 2014 Mar;15(3):324-31</RefSource>                <PMID Version="1">24057661</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mayo Clin Proc. 2014 Sep;89(9):1287-306</RefSource>                <PMID Version="1">25192616</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2000 Apr 13;342(15):1077-84</RefSource>                <PMID Version="1">10760308</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cardiovasc Imaging. 2013 Mar;29(3):571-80</RefSource>                <PMID Version="1">22976877</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Circulation. 2012 Dec 4;126(23):2749-63</RefSource>                <PMID Version="1">23212997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am Heart J. 2012 Feb;163(2):156-63</RefSource>                <PMID Version="1">22305831</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239</RefSource>                <PMID Version="1">23747642</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2005 Dec 1;23(34):8597-605</RefSource>                <PMID Version="1">16314622</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Coll Cardiol. 2010 Jan 19;55(3):213-20</RefSource>                <PMID Version="1">20117401</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JACC Cardiovasc Imaging. 2009 Jan;2(1):80-4</RefSource>                <PMID Version="1">19356538</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2007 Mar 7;99(5):365-75</RefSource>                <PMID Version="1">17341728</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Rev Esp Cardiol (Engl Ed). 2014 Aug;67(8):651-8</RefSource>                <PMID Version="1">25037544</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Can J Physiol Pharmacol. 2013 Aug;91(8):601-7</RefSource>                <PMID Version="1">23889668</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2009 Sep;117(2):357-64</RefSource>                <PMID Version="1">19082707</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Circulation. 2006 Jun 20;113(24):2851-60</RefSource>                <PMID Version="1">16785351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):562-9</RefSource>                <PMID Version="1">23109647</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Can J Cardiol. 2016 Jul;32(7):891-9</RefSource>                <PMID Version="1">27118058</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Soc Echocardiogr. 2014 Sep;27(9):911-39</RefSource>                <PMID Version="1">25172399</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2001 Mar 15;344(11):783-92</RefSource>                <PMID Version="1">11248153</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Echocardiogr. 2011 Nov;12(11):834-40</RefSource>                <PMID Version="1">21880609</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anesth Analg. 2014 Mar;118(3):525-44</RefSource>                <PMID Version="1">24557101</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Soc Echocardiogr. 2013 May;26(5):493-8</RefSource>                <PMID Version="1">23562088</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Heart Fail. 2011 Jan;13(1):1-10</RefSource>                <PMID Version="1">21169385</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Circulation. 2014 Jun 24;129(25):e680-2</RefSource>                <PMID Version="1">24958758</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Oncol. 2010 Aug;17(4):20-33</RefSource>                <PMID Version="1">20697511</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Coll Cardiol. 2013 Jan 8;61(1):77-84</RefSource>                <PMID Version="1">23199515</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">Cardiotoxicity</Keyword>            <Keyword MajorTopicYN="N">Chemotherapy</Keyword>            <Keyword MajorTopicYN="N">Heart failure</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>02</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30359235</ArticleId>            <ArticleId IdType="doi">10.1186/s12885-018-4935-z</ArticleId>            <ArticleId IdType="pii">10.1186/s12885-018-4935-z</ArticleId>            <ArticleId IdType="pmc">PMC6203211</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>